Risk Factors of Coronary Artery Disease in Coronary Artery Bypass Graft Patients: A Cross-sectional Assay from Tehran, Iran

Document Type : Brief Report

Authors

1 Atherosclerosis Research Center, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran

2 Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran

3 Faculty of Medicine, Gilan University of Medical Sciences, Rasht, Iran

4 Student Research Committee, Baqiyatallah University of Medical Sciences, Tehran, Iran

5 Department of Research, Arka Education and Clinical Research Consultants, Tehran, Iran

Abstract

Introduction: Coronary artery disease (CAD) is the leading cause of death in world. In addition, coronary artery bypass graft (CABG), which is known as one of its therapeutic approaches, can cause complications and morbidities that have high costs. We aimed to investigate the distribution of CAD risk factors in patients who underwent CABG in Tehran, Iran.
Methods: The present cross-sectional study included CAD patients who underwent CABG surgery from 20 March 2016 to 20 March 2017 in Baqiyatallah Hospital, Tehran, Iran. The data including the presence of CAD risk factors such as smoking, diabetes, hypertension, presence of CAD family history, and hyperlipidemia, were obtained from the patients’ medical records.
Results: out of 328 patients, 109 (33.3%) were female and 219(66.8%) were male. Their age ranged between 41 to 88 and the mean age (SD) was 62.15 (9.913) years. Finally, 296 patients (90.2%) had at least one symptom and 292 (89%) patients had at least one risk factor. Prevalence of hypertension, hyperlipidemia, diabetes, smoking, and positive familial history was 53.7%, 44.5%, 39.6%, 22.3%, and 16.2% respectively.
Conclusion: The most prevalent risk factor was hypertension followed by hyperlipidemia, smoking, diabetes, and familial history. Also, chest pain was the most frequent symptom among patients. A healthy lifestyle is essential to decrease the prevalence of modifiable risk factors and preventing the presence of CAD and future vascular bypass surgeries in the population.
 

Keywords

Main Subjects


  1. Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke statistics—2019 update: a report from the American Heart Association. Circulation. 2019;139(10):e56-e528.
  2. Wilson PW. Established risk factors and coronary artery disease: the Framingham Study. American journal of hypertension. 1994;7(7_Pt_2):7S-12S.
  3. Members WG, Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, et al. Heart disease and stroke statistics—2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006;113(6):e85-e151.
  4. Hatmi Z, Tahvildari S, Motlag AG, Kashani AS. Prevalence of coronary artery disease risk factors in Iran: a population based survey. BMC cardiovascular disorders. 2007;7(1):32.
  5. Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke Statistics-2019 update a report from the American Heart Association. Circulation. 2019.
  6. Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, et al. Heart disease and stroke statistics—2018 update: a report from the American Heart Association. Circulation. 2018.
  7. Worthley SG, Osende JI, Helft G, Badimon JJ, Fuster V. Coronary artery disease: pathogenesis and acute coronary syndromes. The Mount Sinai journal of medicine, New York. 2001;68(3):167.
  8. Soflaei SS, Varasteh N, Pourali G, Azarkar S, Ghalibaf AM, Mohammadi-Bajgiran M, et al. Association of Metabolic Syndrome and Ischemic Changes in ECG: Result from a Population-Based Study. 2023.
  9. Kannel WB, McGee D, Gordon T. A general cardiovascular risk profile: the Framingham Study. The American journal of cardiology. 1976;38(1):46-51.
  10. Ghalibaf AM, Soflaei SS, Ferns GA, Saberi-Karimian M, Ghayour-Mobarhan M. Association Between Dietary Copper and Cardiovascular Disease: A Narrative Review. Journal of Trace Elements in Medicine and Biology. 2023:127255.
  11. Terry DF, Pencina MJ, Vasan RS, Murabito JM, Wolf PA, Hayes MK, et al. Cardiovascular risk factors predictive for survival and morbidity‐free survival in the oldest‐old Framingham Heart Study participants. Journal of the American Geriatrics Society. 2005;53(11):1944-50.
  12. Ashrafinia F, Moeindarbari S, Razmjouei P, Ghazanfarpour M, Najafi MN, Ghalibaf AAM, et al. Can prenatal and postnatal cell phone exposure increase adverse maternal, infant and child outcomes? Revista Brasileira de Ginecologia e Obstetrícia. 2022;43:870-7.
  13. Talebi S, Sharifan P, Ostad AN, Shariati SE, Ghalibaf AM, Barati M, et al. The Antioxidant and Anti-inflammatory Properties of Chamomile and Its Constituents. Reviews in Clinical Medicine. 2022;9(3).
  14. Mangano DT. Cardiovascular morbidity and CABG surgery—a perspective: epidemiology, costs, and potential therapeutic solutions. Journal of cardiac surgery. 1995;10:366-8.
  15. Safaei N, Alikhah H, Abadan Y. Coronary risk factors in patients underwent coronary artery bypass grafting. Pakistan journal of biological sciences: PJBS. 2011;14(1):25-33.
  16. Karizi Sr, Armanmehr F, Azadi HG, Zahroodi HS, Ghalibaf AM, Bazzaz BSF, et al. A randomized, double‐blind placebo‐controlled add‐on trial to assess the efficacy, safety, and anti‐atherogenic effect of spirulina platensis in patients with inadequately controlled type 2 diabetes mellitus. Phytotherapy Research. 2023;37(4):1435-48.
  17. Thalji NM, Suri RM, Daly RC, Dearani JA, Burkhart HM, Park SJ, et al. Assessment of coronary artery disease risk in 5463 patients undergoing cardiac surgery: when is preoperative coronary angiography necessary? The Journal of Thoracic and Cardiovascular Surgery. 2013;146(5):1055-64. e1.
  18. Karunasumetta C, Laksanabunsong P, Slisatkorn W, Wongkornrat W, Sakiyalak P, Thongcharoen P, et al. Validation of EuroSCORE for coronary artery bypass grafting at Siriraj Hospital. Journal of the Medical Association of Thailand. 2012;95(9):1178.
  19. Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke statistics—2020 update: a report from the American Heart Association. Circulation. 2020:E139-E596.
  20. AkbariRad M, Shariatmaghani SS, Razavi BM, Majd HM, Shakhsemampour Z, Sarabi M, et al. Probiotics for glycemic and lipid profile control of the pre-diabetic patients: a randomized, double-blinded, placebo-controlled clinical trial study. Diabetology & Metabolic Syndrome. 2023;15(1):71.
  21. Abbasi B, Seyed Hosseini M, Moodi Ghalibaf A, Akhavan R, Emadzadeh M, Bolvardi E. Evaluating anemia on non-contrast thoracic computed tomography. Scientific Reports. 2022;12(1):21380.